Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination

A Bitsch1, C Wegener, C da Costa

  • 1Department of Neurology, Georg-August-University, Göttingen, Germany.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 17, 1999
PubMed

Insights

Acute central nervous system (CNS) inflammation precedes demyelination, driven by inflammatory cells and mediators like tumor necrosis factor alpha (TNFalpha) and nitric oxide (NO). Intravenous immunoglobulin (IVIG) may influence immune deposits.

Area of Science:

  • Neuroimmunology
  • Neuropathology

Background:

  • Acute inflammatory central nervous system (CNS) demyelination is a complex process.
  • Understanding the early pathogenetic events is crucial for effective treatment strategies.

Observation:

  • Two stereotactic brain biopsies in a patient with acute CNS demyelination revealed sequential changes.
  • Early biopsy showed inflammatory cell infiltration (macrophages, T lymphocytes) and high mRNA expression of tumor necrosis factor alpha (TNFalpha) and inducible nitric oxide synthase (iNOS), with preserved myelin.
  • Later biopsy demonstrated confluent demyelination with macrophages positive for myelin debris and inflammatory mediators, alongside IgG and C9neo deposits.

Findings:

  • Demyelination follows inflammatory cell migration into CNS white matter.
  • Inflammation alone can cause clinical deficits without demyelination.
  • TNFalpha and nitric oxide (NO) are implicated early in the disease process.
  • Intravenous immunoglobulin (IVIG) treatment may result in immunoglobulin and complement deposition.

Implications:

  • This case highlights the temporal relationship between inflammation and demyelination in the CNS.
  • Early inflammatory mediators play a significant role in CNS demyelinating diseases.
  • The impact of IVIG on immune deposition warrants further investigation in the context of CNS demyelination.

Related Concept Videos

Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...